Lipid peroxidation in patients with schizophrenia.

作者: Anna Dietrich-Muszalska , Bogdan Kontek

DOI: 10.1111/J.1440-1819.2010.02132.X

关键词:

摘要: Aims:  There is evidence that dysregulation of free radicals metabolism associated with abnormal activities antioxidative enzymes in schizophrenia can lead to lipid peroxidation plasma, erythrocytes, blood platelets and cerebrospinal fluid. Injury neurons may affect their function, i.e. membrane transport, impairment energy production mitochondria, changes phospholipid composition, alteration receptors transporters as well neurotransmission. The purpose the present study was assess total antioxidant capacity (TAC) (expressed level thiobarbituric acid reactive substances [TBARS]) plasma from schizophrenic patients taking olanzapine or risperidone. TBARS estimated according Rice–Evans method TAC ([ABTS; 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) radical cation decolorization assay]) (DSM-IV criteria for schizophrenia, n = 30, age 18–36) risperidone healthy volunteers (n = 30) were measured. Methods:  after incubation also estimated. Results:  Significantly lower (P   0.05). obtained results indicate pro-oxidant disturbances occur (acute episode) stable doses risperidone. Conclusion:  It seems second-generation antipsychotics (olanzapine risperidone) are not responsible increase peroxidation.

参考文章(43)
Catherine Rice-Evans, Techniques in Free Radical Research ,(1991)
Grzegorz Bartosz, Total antioxidant capacity. Advances in Clinical Chemistry. ,vol. 37, pp. 219- 292 ,(2003) , 10.1016/S0065-2423(03)37010-6
Haiyun Xu, Haitao Wang, Lixia Zhuang, Bin Yan, Yingxin Yu, Zelan Wei, Yanbo Zhang, Lillian E Dyck, Steven J Richardson, Jue He, Xiaokun Li, Jiming Kong, Xin‐Min Li, None, Demonstration of an anti-oxidative stress mechanism of quetiapine: implications for the treatment of Alzheimer's disease. FEBS Journal. ,vol. 275, pp. 3718- 3728 ,(2008) , 10.1111/J.1742-4658.2008.06519.X
Ömer Akyol, Hasan Herken, Efkan Uz, Ersin Fadıllıoǧlu, Süheyla Ünal, Sadık Söǧüt, Hüseyin Özyurt, Haluk Asuman Savaş, The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients Progress in Neuro-Psychopharmacology and Biological Psychiatry. ,vol. 26, pp. 995- 1005 ,(2002) , 10.1016/S0278-5846(02)00220-8
David F. Horrobin, A.Iain M. Glen, Krishna Vaddadi, The membrane hypothesis of schizophrenia. Schizophrenia Research. ,vol. 13, pp. 195- 207 ,(1994) , 10.1016/0920-9964(94)90043-4
Sahebarao P Mahadik, Denise R Evans, Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications Psychiatric Clinics of North America. ,vol. 26, pp. 85- 102 ,(2003) , 10.1016/S0193-953X(02)00033-3
Anna Dietrich-Muszalska, Beata Olas, Isoprostenes as indicators of oxidative stress in schizophrenia. World Journal of Biological Psychiatry. ,vol. 10, pp. 27- 33 ,(2009) , 10.1080/15622970701361263
Sahebarao P Mahadik, Sukdeb Mukherjee, Russell Scheffer, Elizabeth E Correnti, Jayasri S Mahadik, Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis Biological Psychiatry. ,vol. 43, pp. 674- 679 ,(1998) , 10.1016/S0006-3223(97)00282-5
S. Mukherjee, S.P. Mahadik, E.E. Correnti, R. Scheffer, The antioxidant defense system at the onset of psychosis Biological Psychiatry. ,vol. 35, pp. 701- ,(1994) , 10.1016/0006-3223(94)90967-9
Inge Jeding, Patricia J. Evans, Dola Akanmu, David Dexter, Jeremy D. Spencer, Okezie I. Aruoma, Peter Jenner, Barry Halliwell, Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs Biochemical Pharmacology. ,vol. 49, pp. 359- 365 ,(1995) , 10.1016/0006-2952(94)00424-K